Breaking News

QPharma Appoints Medical Officer

May 17, 2013

Shaw to oversee QLaunch platform

Dr. Peter J. Shaw has been appointed chief medical officer at QPharma. Dr. Shaw will oversee numerous initiatives, including the company’s QLaunch platform designed to maximize compliance and commercial effectiveness of life science product launches.
 
Dr. Shaw previously served as president and chief operating officer of MD Mindset, LLC, a pharma sales force and marketing firm, with responsibility for company operations, product development, and business development. Prior to this, he was president and founder of London-based Metamorph Doctors, Inc., which was established to train medical sales professionals to communicate with physicians more effectively.
 
“Dr. Shaw’s breadth of experience as a physician, executive, and respected key opinion leader in the pharmaceutical industry speaks for itself,” said QPharma president and chief executive officer, Patrick P. Den Boer. “I am confident that he will bring outstanding value to our clients as a core member of our executive leadership team.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.